Patterns of response and acquired resistance to the programmed death‐1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma
Zalaudek, Iris, Corneli, Paola, Vernoni, Sibil, Fedele, Dahlia, Papa, Giovanni, Conforti, Claudio, Retrosi, Chiara, Vezzoni, Roberta, Fagotti, Serena, Longone, Michela, Farinazzo, Eleonora, Meo, NicolLanguage:
english
Journal:
Dermatologic Therapy
DOI:
10.1111/dth.13107
Date:
October, 2019
File:
PDF, 918 KB
english, 2019